Justice Department investigates three Michigan school districts on SOGI instruction

Justice Department investigates three Michigan school districts on SOGI instruction

US and Indonesia workshop combats illegal timber and wildlife trafficking

US and Indonesia workshop combats illegal timber and wildlife trafficking

AG Bondi announces DOJ plan to combat animal welfare crimes

AG Bondi announces DOJ plan to combat animal welfare crimes

Justice Department joins lawsuit against racial discrimination in LA schools

Justice Department joins lawsuit against racial discrimination in LA schools

Mexican national sentenced to 10 years for cocaine trafficking

Mexican national sentenced to 10 years for cocaine trafficking

Justice Department closes 60-year-old Tennessee desegregation case

Justice Department closes 60-year-old Tennessee desegregation case

Honduran nationals indicted for alien smuggling and child sponsorship fraud

Honduran nationals indicted for alien smuggling and child sponsorship fraud

GAO Report on Alaska Tribes' Jurisdiction and Funding Clarity

The GAO released a report highlighting confusion among Alaska Tribes regarding concurrent criminal jurisdiction and eligibility for federal public safety funding. The report recommends the Bureau of Indian Affairs clarify its positions on jurisdiction and establish criteria for new funding agreements to improve transparency.

GAO Report: ICBM Modernization Faces Critical Risks and Opportunities

A GAO report highlights critical risks and opportunities in the Air Force's Sentinel ICBM modernization program. The report notes delays in the missile's first flight, software development challenges, and the need for improved risk management, while also identifying opportunities for cost reduction and schedule mitigation.

GAO Report on NIST IP Guidance and Drug Pricing

A GAO report analyzes draft guidance from NIST on exercising march-in rights under the Bayh-Dole Act, specifically considering product price as a factor. The guidance, still in draft as of December 2025, received significant public support for potentially lowering drug prices, though concerns exist about its impact on innovation.